Biomerica Shares Rise After FDA 510(k) Clearance for H Pylori Bacteria Test
19 December 2023 - 4:25AM
Dow Jones News
By Sabela Ojea
Shares of Biomerica surged Monday after the company said it
received 510(k) clearance for its Hp detect stool antigen Elisa
test, a new product set to detect the H pylori bacteria.
At 11:40 a.m. ET, shares were up 61% at $1.59. The stock has,
however, dropped 58% in the past 12 months.
The biomedical technology company said more than 80% gastric
cancers are associated with H. pylori infection, noting that
gastric cancer is the third most common cause of cancer-related
death on a worldwide basis.
The bacteria infects about 35% of the U.S. population, Biomerica
added.
The 510(k) program accounts for most new medical devices the FDA
reviews to reasonably assure their safety and effectiveness,
according to the FDA's website.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
December 18, 2023 12:10 ET (17:10 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.